Hu X, Li Y, Cao Y, Shi F, Shang L
This guide works through the existing evidence systematically: the molecular biology that makes BPC-157 plausible, the dosing ranges tested in animal models, the limited but growing human data, and the practical considerations around administration route, cycling, and safety
This is your life
Intracrine androgen synthesis may have led to restored AR signaling, leading to a rise in PSA levels and recurrent tumor growth, a relapsed state commonly referred to as castration-resistant prostatic cancer (CRPC) 8
This mechanistic difference suggests the potential for additive effects without direct pharmacological overlap
doi:10.1007/s00432-012-1322-z